Nebenwirkungen · Nimvastid
Nimvastid 1.5 mg orodispersible tablets Nimvastid 3 mg orodispersible tablets Nimvastid 4.5 mg orodispersible tablets Nimvastid 6 mg orodispersible tablets · Abschnitt 4.8 · PDF-Seite 23–24
HOS-210229 · Präparat HOS-154463
23 Cardiac disorders Common Bradycardia Uncommon Atrial Fibrillation Uncommon Atrioventricular block Not known Sick sinus syndrome Vascular disorders Common Hypertension Uncommon Hypotension Gastrointestinal disorders Very common Nausea Very common Vomiting Common Diarrhoea Common Abdominal pain and dyspepsia Common Salivary hypersecretion Hepatobiliary disorders Not known Hepatitis Skin and subcutaneous tissue disorders Common Hyperhydrosis Not known Allergic dermatitis (disseminated) General disorders and administration site conditions Fall Very common Fatigue and asthenia Common Gait disturbance Common Parkinson gait Common
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-17T12:40:00Z · SHA-256 7977a2e740f93e10c6c1dbfee473c4849225e6d1d135ce94de2c91c369b45b63 · Passage 4df58f8a3dce36906b105f1f767aabd900c1323cc9c8bc210dbf016f5e5d95d5 · Zeichen 5378–6631 im Abschnitt